Search

everythinglearnresearchcommunity

for

Search:↓

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Dental erosion is common in adolescents and is linked to diet and higher socioeconomic status.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

HIV-positive pregnant women are more likely to experience severe bleeding, and a pregnant woman with familial hypertriglyceridemia had a successful early delivery with special care.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Women with PCOS have more emotional and body image issues than healthy women.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

The document concludes that proper recognition and treatment of skin appendage disorders are important for management.

Older men and those with a history of skin cancer have a higher risk of getting skin cancer again.

People with polycystic ovary syndrome often experience anxiety and depression.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Understanding how different body systems interact can improve how we prevent or treat frailty in aging.

Kenogen increases with hair loss in women.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Hereditary elliptocytosis causes elongated red blood cells and can lead to mild or no symptoms.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hair loss drugs may cause sexual issues and infertility in men.